Update of safety information on medicinal products containing 3-hydroxy 3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins): atorvastatin; fluvastatin; lovastatin; pitavastatin; pravastatin; rosuvastatin; simvastatin and other relevant fixed-dose combinations, adopted by the PRAC during the review of signals discussed at the meeting of January 6-9, 2023
12.06.2023
2429
In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…
Read more
